BioSpace News Archive

Policy

FDA Proposes Updated Definition of ‘Healthy’ Claim on Food Packages to Help Improve Diet, Reduce Chronic Disease

The U.S. Food and Drug Administration proposed updated criteria for when foods can be labeled with the nutrient content claim “healthy” on their packaging.

September 28, 2022
·
5 min read
Organ on a Chip Market Size Worth USD 209.4 Million in 2028 | Emergen Research

According to the most recent report by Emergen Research, the size of the worldwide organ on a chip market is anticipated to reach USD 209.4 Million in 2028, growing at a steady CAGR of 28.1%.

September 28, 2022
·
8 min read
Rising Government Financing, and Unhealthy Lifestyle Choices are Expected to Drive Revenue Growth of Impaired Glucose Tolerance Treatment Market by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Impaired Glucose Tolerance Treatment Market – Forecast to 2030,’ thoroughly examines the Impaired Glucose Tolerance Treatment industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read
Increasing Prevalence of the Disease among Children Across the Globe is Expected to Drive Osteosarcoma Market Growth by 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Osteosarcoma Market – Forecast to 2030,’ thoroughly examines the Osteosarcoma industry to provide essential data & information for the targeted readers.

September 28, 2022
·
6 min read
Biotech Beach

Vivera Receives 3rd Patent for ZICOH, Expanding Into $500B Prescription Market

Vivera is pleased to announce the U.S. Patent and Trademark Office has granted a third U.S. Patent, No. 11,450,420, for ZICOH, securing the device’s rights as a Secure Smart Dosing System with Automated Delivery, Measurement, and Management for Pills.

September 28, 2022
·
3 min read
NuGen Medical Devices Announces Approval Of Warrant Amendment Application

NuGen Medical Devices Inc. announces that, further to its press release on September 15, 2022, the TSX Venture Exchange has approved the Company’s application to extend the expiry date and reduce the exercise price of an aggregate of 7,500,000 outstanding common share purchase warrants of the Company.

September 28, 2022
·
2 min read
Pharm Country

Mitsubishi Tanabe Pharma America Celebrates Nearly 2,000 ALS Patients Treated With RADICAVA ORS® (edaravone)

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that nearly 2,000 people with amyotrophic lateral sclerosis (ALS) have received RADICAVA ORS® (edaravone).

September 28, 2022
·
9 min read
Pharm Country

CHOP’s Food Allergy Bravery Clinic Helps Kids with Food Allergies Overcome Anxiety

From an early age, children with life-threatening food allergies are taught to proceed with caution: check labels, ask about ingredients, don’t eat something at a friend’s house if you don’t know what is in it.

September 28, 2022
·
5 min read
Biotech Bay

Gladstone Institutes Joins the Parker Institute for Cancer Immunotherapy Network

Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy, the leading network of immuno-oncology expertise in the world, to establish a new research center focused on using genomics and CRISPR technology to program the human immune system to treat cancer.

September 28, 2022
·
4 min read
Business

Atara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, today announced an update to its existing collaboration agreement with Pierre Fabre for the commercialization of tabelecleucel (tab-cel®) for Epstein-Barr virus (EBV)-positive cancers.

September 28, 2022
·
6 min read